Innospec Inc.
IOSP scores 60.2 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.
Minor adjustments (-2.5 points) applied. IOSP's rank of #355 primarily reflects its factor profile relative to the conservative weight vector.
These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.
| Stock | Score | P/E | Rev Growth | Margin | Mkt Cap |
|---|---|---|---|---|---|
| IOSP | 60.2 | 17.3 | -3.7% | 6.6% | $1.9B |
| RGLD | 77.8 | 39.4 | 18.8% | 46.2% | $18.7B |
| LIN | 71.9 | 32.9 | 0.5% | 19.9% | $236.7B |
| BCPC | 71.3 | 39.6 | 3.4% | 13.5% | $5.8B |
| STLD | 67.8 | 23.8 | 3.6% | 6.5% | $27.7B |
| UFPI | 67.6 | 21.2 | -7.8% | 6.2% | $6.1B |
| WDFC | 62.7 | 36.0 | 5.0% | 14.4% | $3.2B |
| KALU | 58.0 | 18.6 | 11.5% | 3.3% | $2.1B |
| SCZM | 53.7 | 13.1 | 5.3% | 25.1% | $1.1B |
| ELE | 53.6 | 105.8 | 29.9% | 15.4% | $1.4B |
| HWKN | 52.3 | 36.9 | 6.0% | 7.8% | $3.1B |
| MEOH | 51.9 | 17.9 | -0.1% | 6.0% | $3.7B |
| AUGO | 51.3 | 13.8 | 42.5% | -5.1% | $7.1B |
| SSRM | 48.6 | 27.3 | -30.2% | -26.2% | $6.2B |
| ALM | 41.8 | N/A | N/A | -216.3% | $3.8B |
| SOLS | 41.5 | 53.9 | 3.1% | 6.1% | $12.7B |
| Sector Average | 41.6 | 37.5 | 40.4% | -552.9% | — |
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Stock is in a downtrend below the 200-day moving average. Price is below both the 50-day and 200-day SMAs, indicating sustained selling pressure.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $456M | $442M | $440M | $441M |
| Gross Profit | $127M | $117M | $123M | $125M |
| Operating Income | $47M | $31M | $34M | $43M |
| Net Income | $47M | $13M | $24M | $33M |
| EPS (Diluted) | $1.91 | $0.52 | $0.94 | $1.31 |
| Gross Margin | 28.0% | 26.4% | 28.0% | 28.4% |
| Operating Margin | 10.3% | 7.0% | 7.8% | 9.6% |
| Net Margin | 10.4% | 2.9% | 5.3% | 7.4% |
| Year | Low | High | Range | Status |
|---|---|---|---|---|
| 2021 | $81.00 | $107.73 | 28.3% | Moderate |
| 2022 | $83.13 | $115.66 | 32.7% | Moderate |
| 2023 | $91.74 | $125.87 | 31.4% | Moderate |
| 2024 | $103.97 | $133.71 | 25% | Moderate |
| 2025 | $70.10 | $117.08 | 50.2% | Wide |
Growth estimates have been dampened based on technical and fundamental signals. This is a post-hoc adjustment to prevent overly optimistic projections for stocks showing declining momentum or deteriorating fundamentals.
Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.